We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current CPH market cap is 203.9M. The company's latest EPS is USD 0.8497 and P/E is 10.00.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 22.45M | 21.61M | 21.94M | 20.68M | 21.16M |
| Operating Income | 6.59M | 6.74M | 11.81M | 13.26M | 11.94M |
| Net Income | 3.24M | 4.55M | 7.76M | 26.64M | 20.38M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 46.46M | 44.28M | 51.65M | 73.78M | 86.03M |
| Total Liabilities | 18.44M | 11.63M | 12.75M | 9.7M | 5.51M |
| Total Equity | 28.01M | 32.64M | 38.9M | 64.08M | 80.52M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 7.93M | 11.69M | 13.81M | 10.58M | 16M |
| Investing | -1.46M | -760k | N/A | -81k | -144k |
| Financing | -10.53M | -8.13M | -2.47M | -1.91M | -5.24M |
| Market Cap | 203.9M |
| Price to Earnings Ratio | 10.00 |
| Price to Sales Ratio | 9.64 |
| Price to Cash Ratio | 5.12 |
| Price to Book Ratio | 2.53 |
| Dividend Yield | - |
| Shares Outstanding | 23.99M |
| Average Volume (1 week) | 24.28k |
| Average Volume (1 Month) | 43.97k |
| 52 Week Change | 153.73% |
| 52 Week High | 9.98 |
| 52 Week Low | 3.11 |
| Spread (Intraday) | 0.23 (2.65%) |
| Company Name | Cipher Pharmaceuticals Inc |
| Address |
209 oak park blvd., suite 501 oakville, ontario L6H 0M2 |
| Website | https://www.cipherpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
